These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3817710)

  • 1. [Value of venoactive substances in phlebology. Treatment of varicose veins and post-thrombotic syndrome].
    Rudofsky G
    Fortschr Med; 1986 Dec; 104(47-48):963-4. PubMed ID: 3817710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic sensitivity of sonography in varicose and post-thrombotic venous insufficiency].
    Petter O; Claus F; Nitzsche H; Böduel S
    Z Hautkr; 1987 Jan; 62(1):12-27. PubMed ID: 2953117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
    Tumino G; Berni A; Tromba L; Marignetti L
    Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of mesoglycan sulfate in primary varices and post-thrombotic syndrome. An evaluation using strain gauge plethysmography].
    Cospite M; Milio G; Ferrara F
    Minerva Med; 1986 Oct; 77(40):1893-8. PubMed ID: 2946006
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].
    Honorato Pérez J; Arcas Meca R
    Rev Med Univ Navarra; 1990; 34(2):77-9. PubMed ID: 2130425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of post-thrombotic syndrome].
    Bollinger A
    Internist (Berl); 1987 May; 28(5):344-55. PubMed ID: 2956215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic activity of oral mesoglycan in venous disease. A clinical and blood coagulation evaluation].
    Bracale GC; Selvetella L; Mirabile F; Ruocco A; Varriale V; De Caterina M
    Minerva Med; 1986 Oct; 77(41):1919-25. PubMed ID: 2946987
    [No Abstract]   [Full Text] [Related]  

  • 9. [The experience of clinical use of lyoton in the varicose disease and post-thrombophlebitic syndrome].
    Klimenko VN; Gaponenko GN
    Klin Khir; 1999; (11):48-9. PubMed ID: 10626417
    [No Abstract]   [Full Text] [Related]  

  • 10. [DHE in phlebology practice].
    Brendel B
    Phlebologie; 1978; 31(4):487-93. PubMed ID: 740738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cutaneous clinical and oximetric findings on the activity mesoglycan, administered per os (100 mg/die), in venous dermatitis].
    Petruzzellis V; Velon A
    Minerva Med; 1986 Oct; 77(41):1911-3. PubMed ID: 2946985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Local therapy with ditaven in some types of venous insufficiency].
    Diaconescu M; Murărescu C; Niculescu D
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(4):564. PubMed ID: 756573
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic venous pathology: presentation of a new international classification].
    Antignani PL; Di Fortunato T
    Clin Ter; 1997 Nov; 148(11):521-6. PubMed ID: 9494253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Diosmin in the therapy of venous diseases.
    Signorelli S; Ferrara M; Tornetta D; Interlandi S; Amico-Roxas MT; Monaco S; Andreozzi GM
    Panminerva Med; 1987; 29(2):165-7. PubMed ID: 3627817
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the clinical use of Essaven gel in treating venous diseases].
    Saenko VF; Sukharev II; Viktorov AP; Goloopykho LI
    Klin Khir; 1996; (7):13-4. PubMed ID: 9044770
    [No Abstract]   [Full Text] [Related]  

  • 16. Constriction of varicose veins and improvement of venous pumping by dihydroergotamine.
    Partsch H; Mostbeck A
    Vasa; 1985; 14(1):74-80. PubMed ID: 3976280
    [No Abstract]   [Full Text] [Related]  

  • 17. [The epidemiology and socio-economics of venous diseases in Germany].
    Wienert V
    Phlebologie; 1993; 46(2):225-33. PubMed ID: 8362005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DHE and venous insufficiency].
    Hickel M
    Phlebologie; 1979; 32(3):309-14. PubMed ID: 493369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Varicose disease: pharmacological treatment].
    De Stefano A; Spinola A; Annoni F
    Ann Ital Chir; 1992; 63(4):423-5. PubMed ID: 1463252
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not.
    Musil D
    Vnitr Lek; 2022; 68(4):234-239. PubMed ID: 36220421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.